The ability of diazepam, a benzodiazepine full agonist, and imidazenil, a benzodiazepine partial agonist, to protect hippocampal area CAl neurons from death for at least 35 days after cerebral ischemia was investigated. Diazepam (10 mg/kg) administered to gerbils 30 and 90 minutes after fore brain ischemia produced significant protection of hippocampal area CAl pyramidal neurons 7 days later. In gerbils surviving for 35 days, diazepam produced the same degree of neuropro tection (70% ± 30%) in the hippocampus compared with 7 days after ischemia. The therapeutic window for diazepam was short; there was no significant neuroprotection when the ad ministration of diazepam was delayed to 4 hours after ischemia.
protected area CAl of hippocampus to the same degree as that by diazepam 7 days after ischemia. At 35 days after ischemia, significant protection remained, but it was considerably re duced compared with 7 days. Like diazepam, the therapeutic window for imidazenil was short. Imidazenil neuroprotection was lost when the drug was administered as early as 2 hours after ischemia. The ability of ischemia to produce deficits in working memory and of benzodiazepines to prevent the deficits also was investigated. Gerbils trained on an eight-arm radial maze before ischemia demonstrated a significant increase in the number of working errors 1 month after ischemia. The isch emia-induced deficits in working memory were completely prevented by diazepam but not by imidazenil. There was a significant, but weak, negative correlation between the degree of CA I pyramidal cell survival and the number of working errors in both the diazepam and imidazenil groups. Thus, if given early enough during reperfusion, both benzodiazepine full and partial agonists are neuroprotective for at least 35 days, but the lack of sedating side effects of imidazenil must be weighed against its reduced efficacy. Key Words: Cerebral ischemia-Benzodiazepine-Neuroprotection-GABA A re ceptor-Working memory-Neuronal death.
area CAl of the hippocampus often is accompanied by anterograde memory loss in humans (Cummings et aI., 1984; Zola-Morgan et aI., 1986) and impairment of working memory in rodents (for review, see Davis and Volpe, 1990; .
The delay in neuronal degeneration provides an op portunity for therapeutic intervention. Because ischemia induced neuronal death involves a cascade of numerous cellular events, the neuroprotective efficacy of several different classes of drugs has been examined. Most neu roprotection studies focus on the excitatory amino acid receptor antagonists, which have produced varying de grees of neuroprotective efficacy, depending on the isch emia model, species, receptor SUbtype, dosing regimen, and presence of hypothermia (Boast et aI., 1987; Gill et aI., 1988; Sheardown et aI., 1990; Buchan and Pulsinelli, 1990; Nellgard and Wieloch, 1992; Li and Buchan, 1993) . In each of these studies, neuroprotection was as sessed at short survival times (less than 7 days). Al though excitatory amino acid receptor antagonists have good neuroprotective efficacy in animal models, their usefulness in humans may be limited because of adverse CNS side effects and peripheral toxicity (Lipton, 1993; Browne and McCulloch, 1994; Foutz et aI., 1994; Xue et aI., 1994; Grotta et aI., 1995) .
Other neuroprotective approaches are successful. One approach is to enhance neuronal inhibition after the isch emic event, thus limiting depolarization and subsequent increases in intracellular calcium. When administered before or after ischemia, drugs that enhance "1aminobutyric acid (GAB A) neurotransmission, such as benzodiazepines, barbiturates and GABA uptake inhibi tors, produce neuroprotection for at least 1 week after ischemia (Levy and Brierley, 1979; Sternau et aI., 1989; Voll and Auer, 1991; Schwartz et aI., 1994; Ingle field et aI., 1995) . We have shown that diazepam, ad ministered early during reperfusion, protects both hippo campus and striatum from cell death 4 to 7 days after ischemia (Schwartz et aI., 1994; . Another neuro protective approach is to produce hypothermia, espe cially in humans (Swain et aI., 1991) . In rodents, the neuroprotective efficacy of postischemic hypothermia depends on the duration of the hypothermia. When hy pothermia is maintained for 24 hours after ischemia in gerbils, neuroprotection of the hippocampus still is evi dent up to 6 months later (Colbourne and Corbett, 1994; . However, in rats and gerbils, the neuroprotection produced by postischemic hypothermia of 3 to 12 hours' duration is either reduced (Colbourne and Corbett, 1994) or lost (Dietrich et aI., 1993; Shuaib et aI., 1995) when assessed 1 and 2 months after ischemia. At shorter sur vival times (l week), even deep hypothermia of less than 3 hours' duration after ischemia fails to be neuroprotec tive in gerbils (Welsh and Harris, 1991) .
The current study addresses issues that are important when assessing the neuroprotective efficacy of drugs. First, we have extended our original findings (Schwartz et aI., 1994) and determined the therapeutic window for diazepam. Second, we determined if diazepam, given after ischemia, can produce long-term protection of py ramidal cells within area CAl of the hippocampus. The neuroprotective efficacy of hypothermia (of similar de gree and duration to that produced by diazepam) also was assessed long term. Third, we determined the neu roprotective efficacy of imidazenil, a benzodiazepine partial agonist that is non sedating (Haefely et aI., 1992; Giusti et aI., 1993) . Last, we also determined if diazepam and imidazenil could prevent ischemia-induced deficits in working memory long term. These results have been presented in preliminary form (Schwartz-Bloom et aI., 1995; Chadwick et aI., 1996) .
METHODS

Subjects
Adult male Mongolian gerbils (50 to 70 g; Tumb1ebrook
Farms, West Brookfield, MA, U.S.A.) were used in all studies.
For behavioral studies, three to four gerbils were group-housed in cages in a room with a radial arm maze, on a 12/ 12-hour light-dark cycle. They had ad libitum access to drinking water but were maintained on a restricted diet to keep their body weight at -85% of free feeding levels. Testing took place dur ing the light phase of the cycle, and gerbils were fed daily after behavioral testing.
Transient forebrain ischemia
Forebrain ischemia was produced by bilateral carotid occlu sion as described previously (Schwartz et aI., 1994) . Briefly, gerbils were anesthetized with 2.5% halothane in breathing air.
A small midline incision was made in the ventral neck, and the carotid arteries were exposed and isolated. Each of the arteries was clamped with aneurysm clamps. Rectal temperature was monitored throughout the surgery and was maintained between 36.5° and 37.5°C by using a heating pad and an incandescent lamp placed over the head. Previously, we showed that these rectal temperatures corresponded to brain temperatures be tween 35.6° and 36.0°C during ischemia (Schwartz et aI., 1994) . Under these conditions, complete degeneration of area CAl was achieved. However, brain temperature was not mea sured in the current studies because of the presence of an in trastriatal thermistor or electrode produces protection in the ipsilateral hippocampus (Armstrong et aI., 1989 and our own observations). The protection may result from spreading de pression elicited by the probe implanted several days before the ischemic episode (Verhaegen et aI., 1992) . After 3 minutes of occlusion, the halothane concentration was reduced to 0.5%.
Five minutes after the onset of ischemia, the clamps were re moved and reperfusion in each artery was verified visually. The incision was closed and a topical antibacterial ointment was applied to the wound. Sham surgery involved the same proce dures except that the arteries were not clamped. All animals regained consciousness after 15 to 20 minutes and recovered in separate cages.
Drug injections
A sedating dose of diazepam (10 mg/kg intraperitoneally) or vehicle (33% polyethylene glycol in saline) was injected 30 and 90 minutes after the onset of ischemia, except in the therapeutic window study. This dosing regimen was previously shown to produce maximal neuroprotection in gerbils when assessed 7 days after ischemia (Schwartz et aI., 1994) . Imidazenil (1 to 6 mg/kg intraperitoneally) was injected 30 and 90 minutes after ischemia as well, except as noted otherwise. In the diazepam group, rectal temperature was monitored for 8 hours from the onset of ischemia (hypothermia lasted about 5 hours). In a previous study, we showed that the brain temperature was -1.YC below the rectal temperature in the presence of diaze pam (Schwartz et aI., 1994) . We did not maintain normother mia after the diazepam injections, since this eliminates the pharmacodynamic action of diazepam (i.e., the gerbils wake up; Schwartz et aI., 1994) . Instead, gerbils were made hypo thermic to simulate the hypothermia produced by diazepam (see later). In a separate experiment, gerbils were injected with the benzodiazepine antagonist flumazenil (10 mg/kg intraperi toneally) 15 minutes before each diazepam injection.
Hypothermia studies
In a separate group of gerbils, hypothermia was induced after ischemia by spraying the shaved back of the gerbils with ice R. D. SCHWAR1Z-BLOOM ET AL.
water, as described previously (Colbourne and Corbett, 1994) .
The degree and duration of hypothermia were produced to mimic the degree and duration of hypothermia produced by diazepam. Rectal temperature was lowered at a rate of approxi mately 1.0°C every 10 minutes to -30.5°C, where it was main tained for 5 hours. After 5 hours of hypothermia, the gerbils were warmed slowly with an incandescent lamp at a rate of 1.0°C every 10 minutes to achieve normothermia. Once gerbils reached 36°C, rectal temperature recording was halted because of excessive movement. Gerbils were killed either 7 or 35 days after ischemia for histologic analysis.
Histology
At day 7 or day 35 after ischemia, the gerbils were sedated deeply by an intraperitoneal injection of pentobarbital (Nem butal, 25 mg) and perfused with phosphate-buffered saline con taining heparin (2 U/mL) followed by phosphate-buffered 4% paraformaldehyde solution. After perfusion, the brains were removed, stored in paraformaldehyde solution for I to 7 days, and transferred to a 30% sucrose-paraformaldehyde solution for 3 to 7 days. The brains were sliced into 30-f.Lm sections using a freezing microtome, and the sections were mounted on slides and stained with thionin or cresyl violet. Stained slices at the level of the dorsal hippocampus 2.0 mm posterior to bregma were analyzed for damage to the CAl sector. An experimenter, blind to the treatments, counted the number of viable cell bod ies remaining in three portions of area CAl (medial, interme diate, and lateral) stratum pyramidale (total area counted was 0.96 or 1.44 mm2, depending on the experiment). The number of surviving neurons in these three areas of CA I were counted in the left and right hemispheres of the brain from at least two dorsal hippocampal slices per animal, and the values were av eraged for each animal.
Working memory performance
Preischemia training. Gerbils were trained and tested for working memory using an eight-arm radial maze, as previously reported (Volpe et aI., 1989; Levin et aI., 1993) , with modifi cations. The maze was constructed with eight arms of 45-cm length and 30-cm height, radiating from a central area diameter of 60 cm. It was located in a testing room with abundant extra maze visual cues to aid in identification of individual arms of the maze. Gerbils were adapted to the maze before training was initiated; they were placed in a black plastic cylinder in the center of the maze with eight Noyes food pellets (45 mg) for 5 minutes or until all of the pellets were eaten. Adaptation lasted for 4 successive days when each gerbil was consuming all eight pellets in less than 5 minutes. Training consisted of 1 session! day, 5 days/week, between 12 and 4 PM for a total of 20 training sessions. Each arm of the eight-arm radial arm maze was baited with a single Noyes food pellet. The gerbils were allowed to enter arms freely for 5 minutes or until all eight pellets were eaten. An entry was recorded every time the gerbil placed all four legs in an arm of the maze, regardless of whether the gerbil went to the end of the arm containing the food pellet. Since the baits were not replaced during the session, the gerbil was re warded only for a first entry into each arm. The sequence of arm entries and pellets eaten was recorded to derive the number of working errors (i.e., the number of reentries into an arm in sessions where all arms had been entered), a measure of choice accuracy. Latency was assessed by measuring the total testing time and dividing it by the total number of entries made. At the conclusion of preischemia behavioral training, the gerbils were assigned to one of four treatment groups (sham, benzodiaze pine, ischemia, and ischemia plus benzodiazepine) based on J Cereb Blood Flow Metah. Vol. 18. No. 5, 1998 their choice accuracy scores, which were balanced among the groups.
Postischemia retesting. After ischemia, the gerbils were housed in individual cages for an additional 35-day survival period. For the first 21 days, the gerbils had unrestricted access to both food and water. On the 21st day, the gerbils were returned to the room where the initial training took place and were placed on a restricted diet to return them to approximately 85% of their ad libitum weight. Twenty-eight days after isch emia, testing was resumed using the same radial arm maze procedure used during the preischemia training period. Testing was carried out "blind" to the surgical procedures undergone by each gerbil. Postischemia testing lasted for five sessions (days).
Data analysis
Behavioral and histologic data were analyzed by multiple analysis of variance and post hoc tests (Scheffe's test or Stu dent's t test with Bonferroni correction) to compare individual groups of means and were performed when interactions be tween variables were significant. Data are reported as the mean ± SD. A probability of P < 0.05 was considered to be statisti cally significant.
RESULTS
Neuroprotection studies with the benzodiazepine full agonist, diazepam
Determination of the therapeutic window. Gerbils were injected with diazepam (10 mg/kg intraperitoneal ly) either 30 and 90 minutes or 4 and 5 hours after the initiation of forebrain ischemia. Seven days after isch emia, there was significant protection (59.2% ± 30.1 %) of hippocampal area CA 1 pyramidal cells in the 30-and 90-minute dosing group, but there was no significant protection in the 4-and 5-hour dosing group (Fig. 1) . In a separate group, the benzodiazepine antagonist, fluma zenil, was injected along with diazepam to demonstrate if the action of diazepam occurred through a benzodiaze pine recognition site. Injections of flumazenil alone did not affect the extent of cell death in area CA 1 of hippo campus (data not shown). However, flumazenil signifi cantly reduced the neuroprotective efficacy of diazepam; only 16% of gerbils were protected (i.e., more than 75% area CAl remained viable) in the presence of flumazenil and diazepam compared with 67% in the presence of diazepam alone (P = 0.03).
Long-term survival studies. Gerbils were injected with diazepam (10 mg/kg) 30 and 90 minutes after 5 minutes of cerebral ischemia. Before the second injection of di azepam, the gerbils became hypothermic as rectal tem perature approached 34°C (Fig. 2 ). After the second in jection of diazepam, the rectal temperature decreased to 32.0° ± 2.1 DC, similar to our previous studies (Schwartz et aI., 1994; 1995a) . This degree of hypothermia lasted -5 hours, and gerbils regained normothermia during the subsequent 2 hours.
By 7 days after cerebral ischemia, there was substan tial loss of pyramidal neurons in area CA 1 of hippocam pus (Figs. 3 and 4) . Approximately 15% of area CAl pyramidal cells remained by 35 days after ischemia. When administered 30 and 90 minutes after ischemia, diazepam produced significant protection (P = 0.0003) of hippocampal pyramidal cells assessed at 7 days ( Fig.  3 ). Complete protection (more than 80% viable cells) of area CAl pyramidal cells was achieved in 37.5% of ger bils, partial protection was achieved in 50% of the ger bils, and no protection was observed in one of the eight gerbils. A similar frequency of neuroprotection was maintained 35 days after ischemia, indicating that sig nificant neuroprotection (P < 0.000 I) persists for at least 5 weeks ( Fig. 3 tion were observed in the medial, intermediate, or lateral portions of area CAl (70% ± 31 % versus 70% ± 30% versus 74% ± 30% protection, respectively), and the pro tected pyramidal neurons appeared histologically normal (Fig. 4 ).
Role of hypothermia in short-and long-term neuroprotection
To address whether the neuroprotection by diazepam resulted from its ability to produce hypothermia, we per formed several experiments. We previously found that maintaining normothermia in an animal injected with diazepam reduced its pharmacodynamic action, as indi cated by a loss of sedation (Schwartz et aI., 1994) . There fore, we simulated the degree and duration of diazepam induced hypothermia by producing hypothermia with a cold-water spray, as described previously (Colbourne and Corbett, 1994 ). Additionally, we tested the neuro protective efficacy of a non sedating benzodiazepine that would be expected to produce little hypothermia (see later).
In the hypothermia studies, the rectal temperature was reduced slowly by a cold-water spray to -30.5°C and maintained at that level for 5 hours (Fig. 5 ). The depth of hypothermia was about 2°C deeper than that produced by diazepam, and the return to normothermia took approxi mately 90 minutes. Although the onset and recovery from hypothermia was slightly earlier than that produced by diazepam, the duration of hypothermia was similar. When gerbils were killed 7 days later, 37.5% were com pletely protected (P < 0.0001) from ischemic damage to the hippocampus (Fig. 6 ). Twenty-five percent of gerbils had no protection. This degree of protection was similar to that produced by diazepam at 7 days after ischemia (Fig. 3) . At 35 days after ischemia, there was no signifi- receptor have been developed with anxiolytic and anti convulsant activity in the absence of sedation produced by the classical benzodiazepines (Haefely et aI., 1992) . Imidazenil, a partial benzodiazepine agonist, does not produce ataxia or sedation in rats in doses 30-to 50-fold higher than those that produce anti conflict effects (Giusti et aI., 1993) . Gerbils were subjected to transient cerebral ischemia and received injections of imidazenil (l to 6 mg/kg intraperitoneally) 30 and 90 minutes after isch emia. Normothermia was maintained in all subjects dur ing ischemia. No significant effects of 1 mg/kg imidaz enil on rectal temperature were observed (Table 1) . Rec tal temperatures decreased slightly (maximum of 0.9° and 1.8°C, respectively) 30 minutes after injection of 3 and 6 mg/kg imidazenil, respectively. This was followed by a return of temperatures toward preinjection values. The limited decrease in temperature contrasts with ex periments in which diazepam (10 mg/kg intraperitoneal Iy) produced marked hypothermia (32°C) after ischemia that lasted for several hours. At doses of 1 to 6 mg/kg, imidazenil did not produce sedation or ataxia. Whereas subjects receiving 3 or 6 mg/kg imidazenil did exhibit decreased spontaneous motor activity during the first 2 hours after ischemia, they were awake and responsive to external stimuli. By 3 hours after ischemia, spontaneous activity had increased considerably. Gerbils were killed 7 days after ischemia for histologic examination. The postischemia administration of imid azenil produced a dose-dependent protection of area CAl pyramidal neurons (Fig. 7 ). Significant neuropro tection was achieved at 1, 3, and 6 mg/kg imidazenil, but the maximal neuroprotective effect of imidazenil was achieved at a dose of 3 mg/kg (this dose was used in subsequent experiments). In the group given 3 mg/kg, there was an average of 53% of area CAl pyramidal cells protected (P < 0.000 I), which was slightly less than that observed with diazepam. Determination of the therapeutic window. When the administration of imidazenil (3 mg/kg) was delayed to 2 and 3 hours or 4 and 5 hours after ischemia, there was no significant protection of area CAl hippocampal neurons (Fig. 8) . This short therapeutic window is similar to that of diazepam, which lost its neuroprotective efficacy when administration was delayed to 4 and 5 hours after ischemia (Fig. 1) .
Long-term survival studies. Experiments also were conducted to determine whether imidazenil could pro duce long-term neuroprotection. Gerbils were killed ei ther 7 or 35 days after ischemia and after having received imidazenil (3 mg/kg). Seven days after ischemia, imid azenil produced significant protection (P < 0.0001) of area CAl pyramidal neurons (Fig. 9 ). Twenty-five per cent of gerbils were completely protected, 62% of gerbils showed partial protection, and one of eight gerbils showed no protection. The frequency of neuroprotection by imidazenil was the same as that by diazepam 7 days after ischemia (compare Figs. 3 and 9 ). By 35 days after ischemia, significant protection still was present (P < 0.05 compared with ischemia; P = 0.43 compared with 7 days), but it had a bimodal distribution (Fig. 9 ). Thirty seven percent of gerbils showed complete protection, and the protected neurons appeared to be normal at 35 days (Fig. 10) . However, the remaining 63% of gerbils treated with imidazenil did not show protection in area CAl of hippocampus. Thus, although the neuroprotective effi cacy of imidazenil was similar to that of diazepam 7 days after ischemia, it was less than that produced by diaze pam 35 days after ischemia. Each point represents an animal; the dotted line represents the mean. Significant protection was achieved at both 7 and 35 days after ischemia (P < 0.0001, ANOVA followed by Scheffe's test).
Working memory performance
Gerbils were trained over 20 sessions to perform a working memory task before the induction of cerebral ischemia. Behavior scores from five sequential sessions were grouped together and analyzed by multiple analysis of variance tests. The number of working errors de creased sequentially over the first 15 sessions (Fig. II) . There was no significant difference between the scores from sessions 11 to 15 and sessions 16 to 20, indicating that the gerbils had reached a stable level of perfor mance. Over the 20-session training period, there was a significant decrease in the latency of response (P < 0.0005 for sessions I to 5 versus sessions 16 to 20), consistent with the development of learning.
One month after the ischemia, the gerbils were re tested on the eight-arm radial arm maze for five sessions (days). There was no significant interaction between re testing session number and treatment. Therefore, the data from the five retesting sessions were averaged for sub sequent group comparisons. There were no significant differences between the sham-vehicle and sham diazepam groups for the number of working errors, and these groups have been combined as a control group (Fig. 12) . Ischemia significantly elevated (246%) the number of working errors (P < 0.0001) in the diazepam study, but the 122% increase in working errors in the imidazenil study was not statistically significant, perhaps because of the small sample size. Diazepam, given early in the postischemic period, completely prevented the im pairment of working memory assessed 1 month later (Fig. 12) . In ischemic gerbils, diazepam reduced the number of working errors (P < 0.0002); their perfor mance was not different from controls. No significant difference from control was observed in imidazenil treated gerbils subjected to ischemia. There were no sig nificant differences in latency among any of the treat ment groups.
J Cereb Blood Flow Metab, Vol. 18, No. 5, 1998 Correlational findings between pyramidal cell viability and behavior Since behavioral and histologic data were available for most of the gerbils in the behavioral study, we deter mined the relation between impairment of working memory deficits and the degree of CAl pyramidal cell survival in the diazepam and imidazenil studies. In the diazepam study, a Spearman rank correlation (r) of the number of working errors (averaged over the 5-day re testing period) versus the number of area CAl pyramidal cells surviving revealed that the number of working er rors increased as the number of surviving CAl pyramidal cells decreased. Although the correlation was significant, it was weak; r = -0.406, P < 0.05. There also was a significant inverse relation in the imidazenil study where r = -0.632, P < 0.05.
DISCUSSION
The findings that emerged from this study include the following: (1) the therapeutic window for neuroprotec tion by diazepam and imidazenil (defined at 7-day sur vival) is narrow (Jess than 4 or less than 2 hours after ischemia, respectively); (2) both diazepam or imidazenil administered early during reperfusion protect CAl hip pocampal pyramidal neurons from degeneration for at least 5 weeks after ischemia, but diazepam has better efficacy; (3) hypothermia of similar duration and depth to that produced by diazepam does not produce long term neuroprotection; and (4) diazepam, a benzodiaze pine full agonist, prevents the deficits in working memory assessed 5 weeks after ischemia.
The therapeutic window for both benzodiazepines as sessed in the short-term survival groups is limited: de laying administration of diazepam to 4 hours after isch emia or of imidazenil to 2 hours after ischemia is no longer neuroprotective. Interestingly, as long as these drugs were administered early enough, repeated dosing over several hours or days was not required for neuro protection. Longer therapeutic windows (up to 12 hours after global ischemia) have been obtained with other neuroprotective agents such as ex-amino-3-hydroxy-5methyl-4-isoxazolepropionic acid receptor antagonists (Li and Buchan, 1993) . The length of time for the thera peutic window for any neuroprotective agent may help to define which cellular processes occurring at a critical time are important to the subsequent development of neuronal death. Thus, depending on the severity of isch emia, neuronal depolarization may persist for several hours after the onset of reperfusion (Hori and Carpenter, 1994) . The depolarization triggers the cascade of events leading to cell death by enabling intracellular levels of calcium to rise (Schurr and Rigor, 1992;  for review). Increasing neuronal hyperpolarization with a benzodiaz epine during this time should be particularly effective at preventing the increase in intracellular calcium. If neu- ronal hyperpolarization is delayed, the opportunity to re duce or prevent the cascade of events leading to cell death may be missed. Longer therapeutic windows for other agents may signify that neurons can still be rescued after interruption of critical cellular processes occurring "downstream."
In prior studies, we demonstrated that diazepam pro tects against ischemia-induced neuronal death for short periods (4 to 7 days) after the ischemic event (Schwartz et aI., 1994; . Here we show that such neuronal protection (and the prevention of memory deficits) is maintained for at least 35 days after ischemia. At short survival times, the diazepam-induced hypothermia may play a significant role in the diazepam neuroprotection of the hippocampus. However, we have shown previously that microinjections of diazepam directly into the hippo campus produces neuroprotection in the absence of any hypothermia (Schwartz et aI., 1995) , indicating that en hancement of GABA neurotransmission directly in the hippocampus can be neuroprotective. In long-term sur- vival animals, the diazepam-induced hypothermia is less likely to play a role in neuroprotection. Several pieces of evidence support this hypothesis. First, hypothermia of similar duration and degree to that produced by diaze pam (the degree of hypothermia here was slightly greater than that produced by diazepam) was not neuroprotective 35 days after ischemia. In contrast, significant neuropro tection in diazepam-treated gerbils persisted 35 days af ter ischemia. Second, neuroprotective efficacy still is achieved with imidazenil, which produces little to no hypothermia for less than 1 hour. Previous studies indi cate that even profound hypothermia of less than 3 hours' duration after ischemia is not neuroprotective in gerbils (Welsh and Harris, 1991) . However, when hypo thermia is prolonged for 24 hours after ischemia, signifi cant neuroprotection still can be observed in gerbils 6 months later (Colbourne and Corbett, 1995) . Compared with diazepam (10 mg/kg) administered with the same dosing regimen, imidazenil (3 mg/kg) has similar neuroprotective efficacy when assessed 7 days after ischemia (60% and 53% protection, respectively). The similar efficacies 7 days after ischemia occur despite the profound hypothermia and sedation produced only by diazepam. Thirty-five days after ischemia, imidazenil's neuroprotective efficacy declined (to 36%) whereas the neuroprotective efficacy of diazepam remained high (69%). Although the average percentage of area CAl neuroprotection declined with time, the percentage of gerbils (37%) exhibiting complete protection of area CAl (35 days after ischemia) was the same whether they were treated with diazepam or imidazeniI. However, 37% of gerbils receiving diazepam also exhibited partial J Cereb Blood Flow Metab, Vol. 18, No. 5, 1998 protection of area CAl , whereas no gerbils receIvmg imidazenil were partially protected 35 days after isch emia. Thus, the two drugs produce similar short-term efficacy, independent of the presence of hypothermia. Long term, imidazenil still has neuroprotective efficacy, but diazepam may be superior because it also produces partial protection not observed in imidazenil-treated ani mals.
The long-term neuroprotection by imidazenil (and di azepam) contrasts with another GAB A-enhancing drug, tiagabine. Tiagabine, a GABA uptake inhibitor, slowed the development of neuronal death after ischemia; neu roprotection was achieved 4 days after ischemia but was lost by 21 days after ischemia (Inglefield et aI., 1995) . Thus, increasing GABA neurotransmission with agents that enhance GABA A receptor sensitivity, such as full or partial benzodiazepine agonists, appears to be superior to increasing GABA concentration in the synapse using a GABA uptake inhibitor (tiagabine). There is considerable evidence that patients who have experienced cerebral ischemia have memory impair ments accompanied by degeneration of pyramidal cells in area CAl of the hippocampus (Cummings et aI., 1984; Volpe and Petito, 1985; Zola-Morgan et a!., 1986) . In rodents, cerebral ischemia produces impairment of work ing and reference memory, although working memory is more sensitive to the ischemic insult (Davis and Volpe, 1990; Kiyota et aI., 1991; . Sev eral investigators have compared the degree of ischemia induced damage to area CA 1 with the degree of working memory impairment. In most cases, there are weak cor relations (but significant) between the degree of area CAl damage and working memory impairment after transient cerebral ischemia (Olsen et aI., 1994b; Whishaw et aI., 1994) , similar to our findings. However, there also are studies in which no correlations (Nunn et aI., 1994) or strong correlations (Kiyota et a!., 1992; Volpe et aI., 1992) have been observed between the de gree of damage to area CA I after ischemia and the de gree of memory impairment. Based on our observations, it appears that at least 75% of cell necrosis in area CAl must be achieved to obtain a significant deficit in work ing memory (using our experimental paradigm). Further more, choice accuracy in gerbils with only partial neu roprotection was within the range of control gerbils. Such thresholds hamper attempts to find a linear asso ciation between the degrees of area CAl damage and working memory deficits. Thus, we support previous hy potheses that although functional CAl pyramidal neu rons contribute to working memory, there is sufficient redundancy within hippocampal and extrahippocampal circuitry to support such function (Bachevalier and Meu nier, 1996) . Furthermore, ischemic damage to extrahip pocampal areas such as entorhinal and cingulate cortex also may contribute to memory deficits (for review, Bachevalier and Meunier, 1996) .
The presence of GABA A receptors on pyramidal neu rons provides a therapeutic target for benzodiazepines to enhance synaptic inhibition on these vulnerable cells. We have found that area CAl interneurons experience isch emia-induced injury (profound dendritic beading), and the dendritic injury is prevented by diazepam long term (Inglefield et aI., 1997) . Whether the protected pyramidal cells (and interneurons) have normal physiologic func tion remains to be tested. Based on the current findings, diazepam (given after ischemia) appears to preserve working memory, a major function of the hippocampus. In contrast, the potential clinical usefulness of benzodi azepine partial agonists without the unwanted side ef fects must be weighed against their reduced long-term neuroprotective efficacy relative to full agonists, such as diazepam.
